SHL Telemedicine (NASDAQ:SHLT) Shares Down 9.7% – Here’s What Happened

by · The Cerbat Gem

Shares of SHL Telemedicine Ltd. (NASDAQ:SHLT – Get Free Report) fell 9.7% during mid-day trading on Friday . The company traded as low as $2.54 and last traded at $2.62. 10,728 shares were traded during mid-day trading, an increase of 207% from the average session volume of 3,495 shares. The stock had previously closed at $2.90.

SHL Telemedicine Trading Down 9.7 %

The company has a quick ratio of 1.98, a current ratio of 2.17 and a debt-to-equity ratio of 0.19. The stock has a 50 day moving average price of $3.25 and a 200-day moving average price of $4.26.

Institutional Investors Weigh In On SHL Telemedicine

A hedge fund recently bought a new stake in SHL Telemedicine stock. Y.D. More Investments Ltd acquired a new position in SHL Telemedicine Ltd. (NASDAQ:SHLT – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 2,219,610 shares of the company’s stock, valued at approximately $11,351,000. SHL Telemedicine comprises about 1.2% of Y.D. More Investments Ltd’s holdings, making the stock its 22nd biggest holding. Y.D. More Investments Ltd owned 15.12% of SHL Telemedicine at the end of the most recent reporting period. 20.11% of the stock is currently owned by institutional investors.

SHL Telemedicine Company Profile

(Get Free Report)

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine solutions in Israel, Europe, and internationally. It offers smartheart, a personal mobile 12 lead ECG device that enables the detection of heart attacks; CardioSen'C, a personal cellular-digital 12-lead ECG transmitter device; and Cardio'B, a portable device to transmit a 12-lead ECG.

Featured Articles